Effective requesting method to detect fusion transcripts in chronic myelomonocytic leukemia RNA-seq.

Area of Science:

• Genomics and Molecular Biology
• Cancer Research
• Bioinformatics

Background:

• Chimeric RNAs are potential biomarkers in malignant cells, but their detection can be challenging.
• Chronic myelomonocytic leukemia (CMML) is a myeloid malignancy with frequent somatic mutations but limited detection of chromosomal abnormalities.
• Cytogenetic aberrations in CMML can impact patient stratification and prognosis, including transformation to acute myeloid leukemia (AML).

Purpose of the Study:

• To develop and validate an integrated k-mer based approach for detecting chimeric RNAs in malignant cells.
• To identify and characterize chimeric RNAs in chronic myelomonocytic leukemia (CMML) patient samples.
• To investigate the potential of chimeric RNAs, such as NRIP1-MIR99AHG, for improving disease stratification in CMML and AML.

Main Methods:

• An integrated approach utilizing k-mers for analyzing indexed next-generation sequencing datasets.
• Application of the method to identify chimeric RNAs in chronic myelomonocytic leukemia (CMML) cells.
• Validation of detected chimeric RNAs and focus on specific fusions like NRIP1-MIR99AHG.

Main Results:

• The developed approach successfully identified four chimeric RNAs in CMML cells.
• The NRIP1-MIR99AHG fusion, previously found in AML, was also detected in CMML.
• Three isoforms of the NRIP1-MIR99AHG fusion were identified, including a novel one.

Conclusions:

• The integrated k-mer based approach is effective for large-scale detection of chimeric RNAs in cancer cells.
• The identified chimeric RNAs, particularly NRIP1-MIR99AHG, may hold significance for understanding CMML biology.
• Further research into these fusions could enhance disease stratification and therapeutic strategies for CMML and AML.